Literature DB >> 16264071

Research conditions that qualify for emergency exception from informed consent.

Drew Watters1, Michael R Sayre, Robert Silbergleit.   

Abstract

Medical research involving critically ill and injured subjects unable to provide informed consent can only be conducted under federal regulations that attempt to balance the need to develop lifesaving treatments with protection of research subjects' rights. Regulators, researchers, and medical ethicists have all struggled to define the conditions under which an emergency exception from informed consent is appropriate. Although research has been successfully conducted under the current regulations, confusion remains regarding the meaning of the regulations, the applicable conditions, and the best ways to balance the needs of future patients and the rights of research subjects. In May 2005, at the Academic Emergency Medicine Consensus Conference "Ethical Conduct of Resuscitation Research," a breakout session was held on the research conditions that qualify for the emergency exception from informed consent process. Several recommendations emerged: 1) The definition of "life-threatening condition" should be broadly interpreted to include serious disability as well as death. 2) Existing therapies should be considered "unsatisfactory," even if partially effective, when serious risk of morbidity or mortality remains even with the best available treatment or when the adverse effects of the best available treatment are serious. 3) Research with the emergency exception should be performed only if sufficient evidence exists that the proposed intervention has a reasonable chance of benefit. 4) More evaluation is needed to determine the degree to which the current rules impede research. 5) Application of the current regulatory framework for abbreviated or waived consent in emergency research should be encouraged. 6) Further study should also address variability among institutional review boards, the goals of community involvement, and how best to engage and educate the public in research efforts using emergency exception from informed consent.

Entities:  

Mesh:

Year:  2005        PMID: 16264071     DOI: 10.1197/j.aem.2005.06.022

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  9 in total

1.  Variation of community consultation and public disclosure for a pediatric multi-centered "Exception from Informed Consent" trial.

Authors:  Maija Holsti; Roger Zemek; Jill Baren; Rachel M Stanley; Prashant Mahajan; Cheryl Vance; Kathleen M Brown; Victor Gonzalez; Denise King; Kammy Jacobsen; Kate Shreve; Katrina van de Bruinhorst; Anne Marie Jones; James M Chamberlain
Journal:  Clin Trials       Date:  2014-11-04       Impact factor: 2.486

Review 2.  Ethical challenges and solutions regarding delirium studies in palliative care.

Authors:  Lisa Sweet; Dimitrios Adamis; David J Meagher; Daniel Davis; David C Currow; Shirley H Bush; Christopher Barnes; Michael Hartwick; Meera Agar; Jessica Simon; William Breitbart; Neil MacDonald; Peter G Lawlor
Journal:  J Pain Symptom Manage       Date:  2013-12-31       Impact factor: 3.612

Review 3.  Clinical trial design in the neurocritical care unit.

Authors:  C E Hall; M Mirski; Y Y Palesch; M N Diringer; A I Qureshi; C S Robertson; R Geocadin; C A C Wijman; P D Le Roux; Jose I Suarez
Journal:  Neurocrit Care       Date:  2012-02       Impact factor: 3.210

4.  [Anesthesia for thrombectomy].

Authors:  S Schönenberger; W Wick; J Bösel
Journal:  Anaesthesist       Date:  2017-09       Impact factor: 1.041

5.  Perceived challenges to obtaining informed consent for a time-sensitive emergency department study of pediatric status epilepticus: results of two focus groups.

Authors:  James M Chamberlain; Kathleen Lillis; Cheryl Vance; Kathleen M Brown; Olubunmi Fawumi; Shari Nichols; Colleen O Davis; Tasmeen Singh; Jill M Baren
Journal:  Acad Emerg Med       Date:  2009-08       Impact factor: 3.451

6.  Patients' perceptions of research in emergency settings: a study of survivors of sudden cardiac death.

Authors:  Neal W Dickert; Nancy E Kass
Journal:  Soc Sci Med       Date:  2008-11-10       Impact factor: 4.634

7.  PRagMatic Pediatric Trial of Balanced vs nOrmaL Saline FlUid in Sepsis: study protocol for the PRoMPT BOLUS randomized interventional trial.

Authors:  Scott L Weiss; Fran Balamuth; Elliot Long; Graham C Thompson; Katie L Hayes; Hannah Katcoff; Marlena Cook; Elena Tsemberis; Christopher P Hickey; Amanda Williams; Sarah Williamson-Urquhart; Meredith L Borland; Stuart R Dalziel; Ben Gelbart; Stephen B Freedman; Franz E Babl; Jing Huang; Nathan Kuppermann
Journal:  Trials       Date:  2021-11-06       Impact factor: 2.728

Review 8.  Clinical research without consent in adults in the emergency setting: a review of patient and public views.

Authors:  Jan Lecouturier; Helen Rodgers; Gary A Ford; Tim Rapley; Lynne Stobbart; Stephen J Louw; Madeleine J Murtagh
Journal:  BMC Med Ethics       Date:  2008-04-29       Impact factor: 2.652

9.  Improving community understanding of medical research: audience response technology for community consultation for exception to informed consent.

Authors:  Taher Vohra; Raphe Bou Chebl; Joseph Miller; Andrew Russman; Anna Baker; Christopher Lewandowski
Journal:  West J Emerg Med       Date:  2014-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.